Amicus Therapeutics (FOLD) Common Stock NPV
0.23%- This stock can be held in a
Create an alert
Stocks and Shares ISASell:$10.93
Buy:$11.04
Change:
$0.10
(0.87%)
$0.10
(0.87%)Market closed |
Prices delayed by at least 15 minutes
Sell:$10.93
Buy:$11.04
Change:$0.10
(0.87%)
$0.10
(0.87%)Market closed |
Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 1 December 2025 | Bradley Lewis (Brad) CampbellPresident/CEO | Sell Option/Award related | 14,587 | $10.01 | $146,011.49 | 1,137,282 |
| 26 November 2025 | Ellen S. RosenbergChief Legal/Compliance Officer | Sell Option/Award related | 23,621 | $10.00 | $236,210.00 | 507,710 |
| 25 November 2025 | Ellen S. RosenbergChief Legal/Compliance Officer | Sell Option/Award related | 36,000 | $10.00 | $360,000.00 | 507,710 |
| 24 November 2025 | Bradley Lewis (Brad) CampbellPresident/CEO | Sell Option/Award related | 14,587 | $10.04 | $146,522.04 | 1,137,282 |
| 24 November 2025 | Ellen S. RosenbergChief Legal/Compliance Officer | Sell Option/Award related | 36,000 | $10.06 | $362,268.00 | 507,710 |
| 24 November 2025 | Jeffrey (Jeff) CastelliChief Level Officer | Sell Regular sell transaction (market) | 76,158 | $10.16 | $773,658.66 | 439,318 |
| 24 November 2025 | David Michael ClarkGroup Director | Sell Regular sell transaction (market) | 25,643 | $10.10 | $258,932.76 | 296,975 |
| 4 November 2025 | David Michael ClarkGroup Director | Sell Regular sell transaction (market) | 25,643 | $9.51 | $243,859.80 | 322,618 |
| 21 August 2025 | Simon N R HarfordCFO | Sell Tax related | 12,529 | $7.60 | $95,220.40 | 214,898 |
| 15 March 2025 | Bradley Lewis (Brad) CampbellPresident/CEO | Sell Tax related | 13,375 | $8.90 | $119,037.50 | 1,137,282 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 24 November 2025 | Jeffrey (Jeff) CastelliChief Level Officer | Sell Regular sell transaction (market) | 76,158 | $10.16 | $773,658.66 | 439,318 |
| 11 February 2025 | Bradley Lewis (Brad) CampbellPresident/CEO | Sell Tax related | 70,711 | $9.57 | $676,704.27 | 1,150,657 |
| 3 January 2025 | Bradley Lewis (Brad) CampbellPresident/CEO | Sell Tax related | 41,474 | $9.41 | $390,270.34 | 1,091,061 |
| 24 November 2025 | Ellen S. RosenbergChief Legal/Compliance Officer | Sell Option/Award related | 36,000 | $10.06 | $362,268.00 | 507,710 |
| 25 November 2025 | Ellen S. RosenbergChief Legal/Compliance Officer | Sell Option/Award related | 36,000 | $10.00 | $360,000.00 | 507,710 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.